3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
19
Glioblastoma
18
Breast Neoplasms
18
Squamous Cell Carcinoma of Head and Neck
15
Lung Neoplasms
12
Rectal Neoplasms
11
Oropharyngeal Neoplasms
10
Neoplasms
9
Head and Neck Neoplasms
9
Glioma
8
Astrocytoma
8
Neoplasm Metastasis
7
Sarcoma
6
Esophageal Neoplasms
6
Carcinoma, Squamous Cell
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Lymphoma, Follicular
5
Hodgkin Disease
5
Gliosarcoma
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Carcinoma
5
Burkitt Lymphoma
5
Brain Neoplasms
5
Adenocarcinoma of Lung
5
Adenocarcinoma Of Esophagus
5
Interventions
pembrolizumab
2
durvalumab
2
Paclitaxel
2
Nivolumab
2
Ipilimumab
2
Doxorubicin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
spartalizumab
1
selinexor
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
balstilimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
Radiotherapy
×
90 days
×
Clear all
No trials found.